Australia's notifiable diseases status, 1999: Annual report of the National Notifiable Diseases Surveillance System

This article published in Communicable Diseases Intelligence Volume 25, No 4, November 2001 contains the 1999 annual report of National Notifiable Diseases Surveillance System. This annual report is available as 32 HTML documents and is also available in PDF format.

Page last updated: 17 December 2001

A print friendly PDF version is available from this Communicable Diseases Intelligence issue's table of contents.

Appendix 1 - Case Definitions

The following table displays the case definitions for other bacterial infections notified to the National Notifiable Diseases Surveillance System in 1999. If you are not able to access these data please e-mail

Appendix 1h. Case definitions and ICD-10 code for notifiable diseases reported to NNDSS in 1999, other bacterial infections

Case definition (NHMRC 1994)
ICD-10 code(s)
Legionellosis A clinically compatible illness (fever, cough or pneumonia)

AND at least one of the following: isolation of Legionella species from lung tissues, respiratory secretions, pleural fluid, blood or other tissues

OR demonstration of Legionella species antigens in lung tissue, respiratory secretions or pleural fluid

OR a four-fold or greater rise in (IFA) titre against Legionella species to at least 128, between acute and convalescent phase sera

OR a stable high Legionella titre (at least 512) in convalescent phase serum

Leprosy Enlarged dermal nerves with associated sensory loss

OR demonstration of acid-fast bacilli (in a skin smear or biopsy specimen)

OR a histological picture compatible with leprosy in a biopsy specimen

Meningococcal infection Isolation of Neisseria meningitidis from a normally sterile site

OR detection of meningococcal antigen in joints, blood or CSF

OR detection of Gram-negative intracellular diplococci in blood or CSF

Tuberculosis Isolation of Mycobacterium tuberculosis, Mycobacterium bovis, or Mycobacterium africanum from a clinical specimen

OR demonstration of acid-fast bacilli in a clinical specimen or in a histopathological lesion, when culture is not available, in a person with signs or symptoms compatible with tuberculosis

OR evidence of resolution of disease where treatment with two or more anti-tuberculosis medications have been prescribed and follow-up has been instigated

A15, A16, A17, A18, A19

This article was published in Communicable Diseases Intelligence Volume 25, No 4, November 2001.

Communicable Diseases Intelligence subscriptions

Sign-up to email updates: Subscribe Now